AHS
Bugs & Drugs 2.0
Publisher DNA
What defines AHS?
AI intelligence is not yet available for AHS. The portfolio data below is up to date.
Portfolio
What does AHS ship?
Apps
2 apps analysed
Analysis in progress
Frequent content updates ensure medical professionals have access to the latest antibiotic treatment standards
- Logical explanation of antibiotic choices provides clear clinical rationale for health practitioners using the reference
- Search functionality freezes the application interface during content queries, disrupting the clinical workflow for users
Single-market publisher, every app ships only to United States.
Based on 1 of 2 apps with localized market data, more coverage rolling in as scans complete · last scanned .
Americas (1)
- United States1 / 1
Core markets (1/1 apps)
User Sentiment
How do users feel about their apps?
1
Positive apps
0
Neutral / mixed
0
Negative apps
75/100
Avg sentiment score
Rivals
Who does AHS compete with?
The rivals identified
Nemeses(1)
Both apps target healthcare professionals and patients seeking medication information, creating direct competition for clinical reference usage. Bugs & Drugs 2.0 focuses on infectious disease guidelines while Drugs.com provides a broader medication database and safety tools.
Same space(1)
MDCalc serves as a bedside clinical decision support tool that complements the infectious disease reference content provided by Bugs & Drugs 2.0.